Risultati per: Linee guida sulla radioterapia per glioma
Questo è quello che abbiamo trovato per te
Farmaceutiche, Valentino Confalone alla guida di EuniPharma
Rappresenta le aziende a capitale europeo e nipponico
Italiani sempre più celiaci, ecco le linee guida per terapia
Sono 224mila i casi diagnosticati, ma si stimano circa 600mila
Italiani sempre più celiaci, ecco le linee guida per terapia
Sono 224mila i casi diagnosticati, ma si stimano circa 600mila
Linee guida sul trattamento sistemico del cancro al seno metastatico
Società Italiana d’Igiene: “guida alle buone pratiche vaccinali”
Linee guida sulla diagnosi e la gestione del cancro al seno precoce e localmente avanzato
Efficacy of cell-based immunotherapies on patients with glioma: an umbrella review of systematic reviews and meta-analysis protocol
Introduction
Glial brain tumours are highly mortal and are noted as major neurosurgical challenges due to frequent recurrence or progression. Despite standard-of-care treatment for gliomas, the prognosis of patients with higher-grade glial tumours is still poor, and hence empowering antitumour immunity against glioma is a potential future oncological prospect. This review is designed to improve our understanding of the efficacy of cell-based immunotherapies for glioma.
Methods and analysis
This systematic review will be performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. A comprehensive search of main electronic databases: PubMed/MEDLINE, Scopus, ISI Web of Science EMBASE and ProQuest will be done on original articles, followed by a manual review of review articles. Only records in English and only clinical trials will be encountered for full-text review. All the appropriate studies that encountered the inclusion criteria will be screened, selected and then will undergo data extraction step by two independent authors. For meta-analyses, data heterogeneity for each parameter will be first evaluated by Cochran’s Q and I2 statistics. In case of possible heterogeneity, a random-effects meta-analysis will be performed and for homogenous data, fixed-effects models will be selected for reporting the results of the proportional meta-analysis. Bias risk will be assessed through Begg’s and Egger’s tests and will also be visualised by Funnel plots.
Ethics and dissemination
As this study will be a systematic review without human participants’ involvement, no ethical registration is required and meta-analysis will be presented at a peer-reviewed journal.
PROSPERO registration number
CRD42022373297
Linee guida sulla gestione dell’artrosi dell’anca
Linee guida sulla dermatite atopica (eczema)
Linee guida sull’emorragia postpartum
Linee guida sulla gestione non chirurgica della lombalgia.
Linee guida sulla gravidanza fisiologica
NICE: linee guida sulla valutazione e gestione del Disturbo Bipolare
In funzione a Veroli radioterapia oncologica ultima generazione
Donato (Ini): ‘Per tumori encefalo, testa-collo, polmone e seno’